Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07261956

Lung Ultrasound for the Detection of Volume Overload in Patients With Severe Preeclampsia

Usefulness of Lung Ultrasound for the Detection of Volume Overload in Patients With Severe Preeclampsia

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
202 (estimated)
Sponsor
Saint Thomas Hospital, Panama · Academic / Other
Sex
Female
Age
Healthy volunteers
Not accepted

Summary

This research aims to evaluate the usefulness of lung ultrasound (LUS) for detecting and monitoring fluid overload in patients with severe preeclampsia. Severe preeclampsia is a leading cause of maternal death and illness worldwide, often causing fluid buildup that can lead to a serious complication called pulmonary edema, especially after delivery. The study will be a prospective, longitudinal observational study with a diagnostic validation component. It will involve patients with a diagnosis of severe preeclampsia who meet specific inclusion criteria. Each participant will undergo a clinical exam and a lung ultrasound, which will assess eight zones of the lungs. The total number of B-lines-a sign of interstitial edema-will be documented. Data will be collected at three key times: upon admission, in the immediate postpartum period (within 24 hours of delivery), and 7-10 days postpartum. The results from the LUS will be compared to clinical signs like shortness of breath, rapid breathing, crackling sounds in the lungs, and oxygen saturation levels. The expected impact of this research is to provide evidence that LUS is a valuable, non-invasive, and accessible tool for the early detection of pulmonary congestion in patients with severe preeclampsia. This could lead to improved clinical decision-making and a reduction in maternal respiratory complications.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTLung ultrasoundLung ultrasounf at three moments (at admission, before delivery and immediate post partum) to determine B Lines

Timeline

Start date
2025-08-25
Primary completion
2025-12-31
Completion
2026-01-31
First posted
2025-12-03
Last updated
2025-12-03

Locations

1 site across 1 country: Panama

Source: ClinicalTrials.gov record NCT07261956. Inclusion in this directory is not an endorsement.